PMA P210036S001

Device
PerClot® Polysaccharide Hemostatic System
Applicant
Baxter Healthcare Corporation
PMA number
P210036
Supplement
S001
Product code
LMG
Decision date
2024-05-08
Classification
General, Plastic Surgery
Generic name
Agent, absorbable hemostatic, non-collagen based
Approval order statement
Approval for a change in the equipment utilized for granularity testing for PerClot Polysaccharide Hemostatic System

Current openFDA PMA Record#

Device
PerClot® Polysaccharide Hemostatic System
Applicant
Baxter Healthcare Corporation
PMA number
P210036
Supplement
S001
Product code
LMG
Generic name
Agent, absorbable hemostatic, non-collagen based
Decision date
2024-05-08
Decision code
APPR
Date received
2023-10-31
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval for a change in the equipment utilized for granularity testing for PerClot Polysaccharide Hemostatic System